Your Article Summary
See Latest ArticlesGout - what are the treatment options
Expert Opinion in Pharmacotherapy, 05/28/09
Schlesinger N et al. - The recent development of new therapeutic options promises to provide much needed alternatives for the many patients with gout who are intolerant of or refractory to available therapies. It is important to note that inappropriate use of medications as opposed to an apparent refractoriness to available therapies is not uncommon.
Related Articles
Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09
Relevance Score: 91%
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
Relevance Score: 89%
Progress in Measurement Instruments for Acute and Chronic Gout Studies
Journal of Rheumatology, 10/23/09
Relevance Score: 88%
Gout in young migrant Filipino women in Israel: a changing epidemiology. Case reports and review of the literature
Rheumatology International, 10/22/09
Relevance Score: 87%
The modern management of gout
Rheumatology, 10/08/09
Relevance Score: 87%
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
The modern management of gout
Rheumatology, 10/08/09
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09